KIMBERLIE NOYES: Open Payments
NPI 1700429461 · CANANDAIGUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 58 payments from 10 companies in 2025. Trend: 2023 $1,324 · 2024 $1,762 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $319 |
| ABBVIE INC. | 19 | $302 |
| Lundbeck LLC | 6 | $155 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AIRSUPRA, Auvelity, AUSTEDO XR, TRINTELLIX, HETLIOZ.
Industry payments across NY — which companies pay providers there.
